Accelerating how new drugs are made with machine learning

Researchers have developed a platform that combines automated experiments with AI to predict how chemicals will react with one another, which could accelerate the design process for new drugs.

Predicting how molecules will react is vital for the discovery and manufacture of new pharmaceuticals, but historically this has been a trial-and-error process, and the reactions often fail. To predict how molecules will react, chemists usually simulate electrons and atoms in simplified models, a process which is computationally expensive and often inaccurate.

Now, researchers from the University of Cambridge have developed a data-driven approach, inspired by genomics, where automated experiments are combined with machine learning to understand chemical reactivity, greatly speeding up the process. They’ve called their approach, which was validated on a dataset of more than 39,000 pharmaceutically relevant reactions, the chemical ‘reactome’.

Their results, reported in the journal Nature Chemistry, are the product of a collaboration between Cambridge and Pfizer.

“The reactome could change the way we think about organic chemistry,” said Dr Emma King-Smith from Cambridge’s Cavendish Laboratory, the paper’s first author. “A deeper understanding of the chemistry could enable us to make pharmaceuticals and so many other useful products much faster. But more fundamentally, the understanding we hope to generate will be beneficial to anyone who works with molecules.”

The reactome approach picks out relevant correlations between reactants, reagents, and performance of the reaction from the data, and points out gaps in the data itself. The data is generated from very fast, or high throughput, automated experiments.

“High throughput chemistry has been a game-changer, but we believed there was a way to uncover a deeper understanding of chemical reactions than what can be observed from the initial results of a high throughput experiment,” said King-Smith.

“Our approach uncovers the hidden relationships between reaction components and outcomes,” said Dr Alpha Lee, who led the research. “The dataset we trained the model on is massive — it will help bring the process of chemical discovery from trial-and-error to the age of big data.”

In a related paper, published in Nature Communications, the team developed a machine learning approach that enables chemists to introduce precise transformations to pre-specified regions of a molecule, enabling faster drug design.

The approach allows chemists to tweak complex molecules — like a last-minute design change — without having to make them from scratch. Making a molecule in the lab is typically a multi-step process, like building a house. If chemists want to vary the core of a molecule, the conventional way is to rebuild the molecule, like knocking the house down and rebuilding from scratch. However, core variations are important to medicine design.

A class of reactions, known as late-stage functionalisation reactions, attempts to directly introduce chemical transformations to the core, avoiding the need to start from scratch. However, it is challenging to make late-stage functionalisation selective and controlled — there are typically many regions of the molecules that can react, and it is difficult to predict the outcome.

“Late-stage functionalisations can yield unpredictable results and current methods of modelling, including our own expert intuition, isn’t perfect,” said King-Smith. “A more predictive model would give us the opportunity for better screening.”

The researchers developed a machine learning model that predicts where a molecule would react, and how the site of reaction vary as a function of different reaction conditions. This enables chemists to find ways to precisely tweak the core of a molecule.

“We pretrained the model on a large body of spectroscopic data — effectively teaching the model general chemistry — before fine-tuning it to predict these intricate transformations,” said King-Smith. This approach allowed the team to overcome the limitation of low data: there are relatively few late-stage functionalisation reactions reported in the scientific literature. The team experimentally validated the model on a diverse set of drug-like molecules and was able to accurately predict the sites of reactivity under different conditions.

“The application of machine learning to chemistry is often throttled by the problem that the amount of data is small compared to the vastness of chemical space,” said Lee. “Our approach — designing models that learn from large datasets that are similar but not the same as the problem we are trying to solve — resolve this fundamental low-data challenge and could unlock advances beyond late stage functionalisation.”

The research was supported in part by Pfizer and the Royal Society.

Share Button

Water molecule discovery contradicts textbook models

Textbook models will need to be re-drawn after a team of researchers found that water molecules at the surface of salt water are organised differently than previously thought.

Many important reactions related to climate and environmental processes take place where water molecules interface with air. For example, the evaporation of ocean water plays an important role in atmospheric chemistry and climate science. Understanding these reactions is crucial to efforts to mitigate the human effect on our planet.

The distribution of ions at the interface of air and water can affect atmospheric processes. However, a precise understanding of the microscopic reactions at these important interfaces has so far been intensely debated.

In a paper published today in the journal Nature Chemistry, researchers from the University of Cambridge and the Max Planck Institute for Polymer Research in Germany show that ions and water molecules at the surface of most salt-water solutions, known as electrolyte solutions, are organised in a completely different way than traditionally understood. This could lead to better atmospheric chemistry models and other applications.

Technique

The researchers set out to study how water molecules are affected by the distribution of ions at the exact point where air and water meet. Traditionally, this has been done with a technique called vibrational sum-frequency generation (VSFG). With this laser radiation technique, it is possible to measure molecular vibrations directly at these key interfaces. However, although the strength of the signals can be measured, the technique does not measure whether the signals are positive or negative, which has made it difficult to interpret findings in the past. Additionally, using experimental data alone can give ambiguous results.

The team overcame these challenges by utilising a more sophisticated form of VSFG, called heterodyne-detected (HD)-VSFG, to study different electrolyte solutions. They then developed advanced computer models to simulate the interfaces in different scenarios.

The combined results showed that both positively charged ions, called cations, and negatively charged ions, called anions, are depleted from the water/air interface. The cations and anions of simple electrolytes orient water molecules in both up- and down-orientation. This is a reversal of textbook models, which teach that ions form an electrical double layer and orient water molecules in only one direction.

Co-first author Dr Yair Litman, from the Yusuf Hamied Department of Chemistry, said: “Our work demonstrates that the surface of simple electrolyte solutions has a different ion distribution than previously thought and that the ion-enriched subsurface determines how the interface is organised: at the very top there are a few layers of pure water, then an ion-rich layer, then finally the bulk salt solution.”

Co-first author Dr Kuo-Yang Chiang of the Max Planck Institute said: “This paper shows that combining high-level HD-VSFG with simulations is an invaluable tool that will contribute to the molecular-level understanding of liquid interfaces.”

Professor Mischa Bonn, who heads the Molecular Spectroscopy department of the Max Planck Institute, added: “These types of interfaces occur everywhere on the planet, so studying them not only helps our fundamental understanding but can also lead to better devices and technologies. We are applying these same methods to study solid/liquid interfaces, which could have potential applications in batteries and energy storage.”

Share Button

Flight Attendant Shares The 1 Seat She Always Avoids On Planes

I feel like “I’ll sleep on the plane there” falls into the same category as “I’ll let it soak” ― they’re both little but destructive lies we tell ourselves when we’re too stressed or tired to think through the reality of a situation.

And like facing a clogged-up sink hours after you said you’d clean that grimy pot, taking an exhausted exit from a plane only to face a groggy 12 hours of activities in a new country can be completely overwhelming.

Luckily, it turns out there’s a trick that only the pros know to help ensure a great nap while you’re travelling ― recently, a former British Airways flight attendant, shared with The Express where to avoid sitting to get your best shot at sleep.

What’s that then?

“If you book the middle aisle front row on a long-haul flight, yes you might get some extra leg room, but you’re more than likely to be sat next to a baby,” she said.

“This is because this seat has a fold-down table for cots/bassinets for babies to sleep instead of on someone’s lap for the whole flight.”

So, if the infant you’re sat beside is particularly vocal or fussy, it might be hard to drown out their cries well enough to nod off.

The former flight attendant also told The Express that while a window seat is often comfiest for mid-flight naps (you need something to rest your head on that isn’t an irritated stranger’s shoulder, after all), there’s one job we should all do there if we want to catch some pre-holiday Zzzs.

“If you’re at a window seat and planning to get some sleep (particularly when flying through the night into daylight) close your blind after take-off,” she told the publication.

That’s because those who don’t remember to shut their blinds will have flight attendants “climbing” all over them to close it for them. After all, they need to be down during takeoff and landing ― and, of course, it’s better for blocking daylight.

It’s also a good idea to stay in the back of the plane, she added.

Anything else?

Yep! We’ve written before about how everything from a good neck pillow to meditation can help you fall asleep on a plane.

And Phil Dengler, co-founder of The Vacationer, previously told HuffPost that how you dress is key.

“The most common mistake people make on long-haul flights is not dressing properly,” he said. “Since you will be sitting in the same seat for six or more hours, it is essential to be as comfortable as possible.”

The middle aisle of the front row isn’t the only seat you should avoid on a flight, either ― “Sitting near the restroom may sound convenient, but it’s never fun to be in that row when a line forms outside the restroom,” said Paul Jacobs, general manager and vice president at Kayak North America, told HuffPost.

So, dress comfy, cushion up, avoid the middle front aisle seat, pull those blinds down, and skip the pre-loo view if you can, the pros say. Noted.

Share Button

Weight-loss surgeon told patient to ‘eat, eat, eat’

Turkish surgeon Ogün Erşen told an undercover BBC reporter she could qualify for gastric sleeve surgery if she ate “some snacks”.

Share Button

NHS ‘thought St Albans cancer patient was from Traveller community’

Angela Devlin, 26, says she was not offered a check as it was assumed she would not have an address.

Share Button

Bariatric tourism care costs NHS more than actual surgery – study

Data from five hospitals shows the NHS spent £560,000 on 35 patients in 2022 after surgery abroad.

Share Button

Few older adults use direct-to-consumer health services; Many who do don’t tell their regular provider

Only a small percentage of older Americans have jumped on the rising trend of getting health care services and prescriptions directly from an online-only company, rather than seeing their usual health care providers in person or via telehealth, a new poll finds.

But that could change rapidly, the University of Michigan survey suggests.

In all, 7.5% of people between the ages of 50 and 80 have used at least one direct-to-consumer health care service from an online-only provider, according to the new findings from the National Poll on Healthy Aging (https://www.healthyagingpoll.org/).

Of those who did use such a service, most said they were driven by convenience. More than 60% of them received a prescription, mostly for a one-time treatment. But only one-third of them told their regular health care provider about the prescription.

People in their pre-Medicare years of 50 to 64 were more than twice as likely as adults over 65 to have used direct-to-consumer, or DTC, online health services (10% vs. 4%). Meanwhile, 47% of those over 65 said they had never heard of such companies.

Looking to the future, nearly a third of all older adults, and more than 42% of those age 50 to 64, said they’d be interested in using such services in the future.

The poll is based at the U-M Institute for Healthcare Policy and Innovation, and supported by AARP and Michigan Medicine, U-M’s academic medical center.

For the DTC survey, the poll team worked with members of U-M’s Center for Value-Based Insurance Design, who are interested in how cost and convenience influence people’s health care decisions and the continuity of care delivery.

A rapidly growing sector spurs concerns

The rise of DTC sites and subscription-based apps that promise convenient online access to providers who can evaluate symptoms, make diagnoses and prescribe medicines has received a lot of attention, especially amid a national crunch in availability of primary care providers and timely appointments.

Such companies include Amazon Clinic, Sesame, Roman, BetterHelp, Rosy, Lemonaid, Hims & Hers, and don’t require a referral or health insurance. Drug companies and membership-based organizations including Weight Watchers and Costco have also started offering access to such direct services.

But the trend has raised concern because of the potential for patients to receive care and prescriptions from providers who don’t know their full health history, don’t have access to their full medical records, and may not check for potentially dangerous interactions between medications.

One-third of those who had used a DTC service said their primary care provider wasn’t aware they had done so. If they received a new prescription through an encounter with a DTC health service, one-third said their regular primary care provider was not made aware of the new medication they were prescribed. The majority of those who received prescriptions through a DTC service said it was for a one-time treatment.

“These compelling findings have important implications for patient safety and continuity of care,” said Mark Fendrick, M.D., director of VBID and IHPI member who is a primary care physician at Michigan Medicine. “With rapid growth in this sector of health care predicted for this year and beyond, all providers, insurers and regulators need to pay more attention to how patients are using these services and why, and the impact on care quality and safety.” Fendrick is a professor of internal medicine in the Division of General Medicine at the U-M Medical School.

His colleague Nicole Hadeed, M.D., who also worked on the poll and is a clinical assistant professor, notes that while the number of poll participants who said they had used DTC services was relatively small, the analysis gives clues that should inform further research.

Types of care received

Nearly half of those who had used a DTC service said it has been for general health care such as treatment of allergies, sinus infections, pink eye or acid reflux, though again there was a clear divide between the 50-64 and 65-80 age groups.

Overall, nearly 12% said they’d used a service for mental health reasons, but the proportion was much higher (50%) among respondents who said they considered their mental health to be fair or poor and had used a DTC service of any kind.

As for other types of care, 15% had sought help from a DTC service for a sexual health issue, 9% had used it for skin care, 6% had used it for weight management, nearly 5% had used it for hair loss and a similar percentage had used it for pain management.

Convenience topped the list of reasons for choosing a DTC service, with 55% saying this drove their decision. But lack of access to their regular health care provider, not having a regular health care provider, or needing a service when their health provider was not open or available were each cited by around 20%. Discomfort discussing a sensitive health topic with a provider — often cited in marketing by such companies — was only mentioned by 10% of those who had turned to a DTC service.

“For both patients and providers, these findings drive home the importance of open dialogue and transparency about the potential uses, benefits and risks of these services — and the importance of maintaining contact for ongoing primary care,” said Jeffrey Kullgren, M.D., M.P.H., M.S., director of the poll and a primary care provider at the VA Ann Arbor Healthcare System who is also an associate professor at the Medical School.

More than 55% of the poll respondents who had used a direct-to-consumer service said the overall quality of care they get from their primary care provider is better than what they received from a DTC provider.

Fendrick and Hadeed wrote about the potential long-term change to primary care use from telehealth services in a piece published early in the COVID-19 pandemic in the American Journal of Managed Care.

And in fact, 58% of poll respondents who had used a DTC service had started doing so in 2020, 2021 or 2022.

The rapid pivot during the pandemic to vaccination in pharmacies, and not just primary care clinics, has also changed how people think about alternate ways of getting care that might be closer to home or have more flexible hours.

However, Fendrick notes, pharmacies share information about vaccination with insurance companies and statewide immunization registries that primary care providers can access.

“Patients will increasingly seek care online because of the convenience it can provide, especially for those willing to pay the cost out of pocket,” said Fendrick. “Its use will likely be boosted by the rapidly increasing number of online vendors and the national shortage of primary care clinicians. The recent launch of a telemedicine platform offering home delivery for the new highly popular weight loss drugs is a noteworthy example of this trend.”

He added, “Given a likely expansion of online care, it is critical that individuals inform their usual clinician and that we providers consistently ask our patients regarding their use. Similar to my routinely asking patients about which supplements, vitamins and over-the-counter medications they’re taking, it should become standard practice for me to inquire about prescriptions or diagnoses they’ve received online, as it might influence their care.”

The poll was a nationally representative survey conducted by NORC at the University of Chicago for IHPI and administered online and via phone in July and August 2023 among 2,657 adults aged 50 to 80. In all, 168 respondents reported having used a DTC health care service. The sample was subsequently weighted to reflect the U.S. population. Read past National Poll on Healthy Aging reports (https://www.healthyagingpoll.org/reports-more) and about the poll methodology (https://www.healthyagingpoll.org/survey-methods).

Share Button

Keir Starmer Waters Down Pledge To End Arms Sales To Saudi Arabia

Keir Starmer has watered down his previous pledge to end arms sales to Saudi Arabia if he becomes prime minister.

The Labour leader would only commit to a “review” of the policy if he becomes prime minister.

Starmer also appeared to row back on his previous commitment to bring in a new law forcing the government to seek parliamentary approval for any military action.

When he was running to succeed Jeremy Corbyn in 2020, Starmer said the UK “should stop the sales of arms to Saudi Arabia”.

But on Sunday with Laura Kuenssberg this morning, he said: “We will do a review to look at the sales, look at the countries and the relationships that we have. Obviously, that follows a review.”

Kuenssberg told him: “But you said in February 2020 ‘we should stop the sale of arms to Saudi Arabia’. Is that still your position?”

Starmer replied: “We will review the situation and the review will give us the answer to those questions.”

Kuenssberg said: “So you may not any more promise to stop the sale of arms to Saudi Arabia, which is what you used to say in 2020.”

Starmer said: “We will review the situation and the review will make clear what the position is.”

During his leadership campaign, Starmer pledged to “end illegal wars” by introducing a Prevention of Military Intervention Act.

That would ensure that any military action had to be legal and backed by a Commons vote.

However, Starmer backed last week’s air strikes on Houthi rebels in Yemen despite there being no vote in parliament beforehand.

Asked about the apparent change of heart, the Labour leader insisted there was “no inconsistency” in his position.

He said: “There is a huge distinction between an operation the like of which we’ve seen in the last few days and a sustained campaign – military action usually involving troops on the ground.

“National security must come first. There will always be urgent situations where parliament can’t be consulted beforehand. But the principle that if there’s to be a sustained campaign, if we’re going to deploy our troops on the ground, that parliament should be informed, there should be a debate, the case should be made and there should be a vote, I do stand by that in principle, absolutely.”

However, Starmer refused to commit to introducing a new law, saying it could be “done by some other means”.

Share Button

David Cameron Says It Is ‘Nonsense’ To Claim Israel Is Committing Genocide In Gaza

David Cameron has said it is “nonsense” to say Israel is committing genocide in Gaza.

His comments came after South Africa presented a case to the United Nations accusing Tel Aviv of “genocidal acts”.

Israel has been bombing Gaza for the past three months in retaliation for the terrorist attack on the country by Hamas on October 7.

Tens of thousands of civilians have died as a result of the bombardment, which has led to a humanitarian crisis.

But appearing on Sunday Morning with Trevor Phillips today, Lord Cameron rejected South Africa’s accusations.

The foreign secretary said: “I think the South African action is wrong, I think it’s unhelpful, I think it shouldn’t be happening.

“I’m not a lawyer, but they are talking here about genocide. To prove that, you’ve got to prove that there was intent.

“I take the view that Israel is acting in self defence after the appalling act on October 7. But even if you take a different view to my view, to look at Israel – a democracy, a country with the rule of law, a country with armed forces that are committed to obeying the rule of law – to say that they have the intent to commit genocide, I think that is nonsense, I think that’s wrong.”

Phillips told him: “You can’t know that, you can only judge on the basis of what they’ve done.”

But Lord Cameron insisted that “to say there’s the intent to commit genocide, I do believe that’s wrong”.

South Africa has called for the emergency suspension of Israel’s aerial and ground offensive, claiming it was looking to induce “the destruction of the population” of Gaza.

But Israel has rejected these claims, accusing South Africa of playing “advocate of the devil” for Hamas. It says it is not targeting any civilians, but the militants.

Share Button

Luciana Berger Given Labour Role Five Years After Quitting Party

Luciana Berger has been given a key role by Labour leader Keir Starmer five years after quitting the party.

The former MP will lead a mental health strategic review ahead of the general election later this year.

Berger left Labour over its “culture of bullying, bigotry and harassment” in 2019 and ended up fighting the election that year for the Liberal Demcrats.

She rejoined last year after Starmer personally apologised for the “intimidation, thuggery and racism” she endured when Jeremy Corbyn was leader.

Speaking at the Jewish Labour Movement conference today, Starmer said she will work with shadow health secretary Wes Streeting and shadow mental health minister Abena Oppong-Asare to deliver a long-term cross-government strategy for mental health.

He said: “I am proud to welcome Luciana back. The Labour Party has changed beyond recognition since she was forced out, and we will be a richer party for having her working with us again.

“It will be the mission of my Labour government to make sure fewer lives are lost to suicide, with timely support available to all who need it.

“Luciana is a fierce advocate for mental health and her work will contribute to achieving that mission in government.”

Berger, who was Labour MP for Liverpool Wavertree between 2010 and 2019, said: “With Keir Starmer’s leadership, Labour has turned a significant corner. I am delighted to be back working with my party and helping Labour deliver the change our country really needs.”

was one of seven Labour MPs who quit the party in 2019 to form Change UK in protest at Corbyn’s leadership.

She said at the time: “I cannot remain in a party which I have come to the sickening conclusion is institutionally anti-Semitic.”

She eventually switched to the Lib Dems and stood for the party in Finchley and Golders Green at the 2019 election, but was defeated by the Conservatives’ Mike Freer.

Share Button